bioRxiv · 10.1101/2020.03.15.992982
Rapidly induced drug adaptation mediates escape from BRAF inhibition in single melanoma cells
Abstract
Despite increasing numbers of effective anti-cancer therapies, successful treatment is limited by the development of drug resistance. While the contribution of genetic factors to drug resistance is undeniable, little is known about how drug-sensitive cells first evade drug action to proliferate in drug. Here we track the response of thousands of single melanoma cells to BRAF inhibitors and show that a subset escapes drug within the first 3 days of treatment. Cell-cycle re-entry occurs via a non-genetic mechanism involving activation of mTORC1 and ATF4, validated in cultures of patient biopsies. These escapees cycle periodically in drug, incur significant DNA damage, and out-proliferate non-escapees over extended treatment. Our work reveals a mutagenesis-prone, expanding subpopulation of early drug escapees that may seed development of permanent drug resistance.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
yang, c., Tian, C., Hoffman, T. E., Jacobsen, N. K., Spencer, S. L.. 2020-03-17. Rapidly induced drug adaptation mediates escape from BRAF inhibition in single melanoma cells. https://doi.org/10.1101/2020.03.15.992982
Cite the original work for its findings. Save a collection to share your selection of sources.